Your browser doesn't support javascript.
loading
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia.
Li, Na; Lopez, Michael A; Linares, Maria; Kumar, Subodh; Oliva, Stefania; Martinez-Lopez, Joaquin; Xu, Lian; Xu, Yan; Perini, Tommaso; Senapedis, William; Baloglu, Erkan; Shammas, Masood A; Hunter, Zachary; Anderson, Kenneth C; Treon, Steven P; Munshi, Nikhil C; Fulciniti, Mariateresa.
Affiliation
  • Li N; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Lopez MA; Department of Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Liaoning, China.
  • Linares M; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kumar S; Hospital Universitario 12 de Octubre, Complutense School of Medicine, Spanish National Cancer Research Centre, Madrid, Spain.
  • Oliva S; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Martinez-Lopez J; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy.
  • Xu L; Hospital Universitario 12 de Octubre, Complutense School of Medicine, Spanish National Cancer Research Centre, Madrid, Spain.
  • Xu Y; Bing Center for Waldenstrom's macroglobulinemia, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Perini T; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Senapedis W; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Baloglu E; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Shammas MA; Karyopharm Therapeutics Inc., Newton, Massachusetts.
  • Hunter Z; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Anderson KC; VA Boston Healthcare System, Boston, Massachusetts.
  • Treon SP; Bing Center for Waldenstrom's macroglobulinemia, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Munshi NC; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Fulciniti M; Bing Center for Waldenstrom's macroglobulinemia, Dana Farber Cancer Institute, Boston, Massachusetts.
Clin Cancer Res ; 25(1): 369-377, 2019 01 01.
Article in En | MEDLINE | ID: mdl-30206161
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Cytokines / Waldenstrom Macroglobulinemia / Nicotinamide Phosphoribosyltransferase / P21-Activated Kinases / Aminopyridines Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Cytokines / Waldenstrom Macroglobulinemia / Nicotinamide Phosphoribosyltransferase / P21-Activated Kinases / Aminopyridines Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article